215190-25-3,
(3S)-Fmoc-3-amino-1-carboxymethyl-valerolactame,
1-Piperidineaceticacid, 3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-2-oxo-, (3S)-,
Fmoc-(3S)-3-1-carboxymethyl-2-valerolactame,
AC1MBT1C,
SCHEMBL800117,
CTK1A0085,
DTXSID90373295,
ZINC2545947,
MFCD02179648,
AKOS027250939,
AJ-39326,
RT-012771,
Z5759,
[(3S)-3-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)-2-oxopiperidin-1-yl]acetic acid,
2-[(3S)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-2-oxopiperidin-1-yl]acetic acid,
C22H22N2O5,
CID2756205,
1-Piperidineaceticacid,3-[[ carbonyl]amino]-2-oxo-, -,
2-[3-(9H-fluoren-9-ylmethoxycarbonylamino)-2-oxo-1-piperidyl]acetic Acid,
(S)-2-(3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-oxopiperidin-1-yl)acetic acid,